Biodesix to Provide COVID-19 Testing for Colorado State University Campus
By: Colorado BioScience Association Date: 08/12/2020
Biodesix, Inc., a leading diagnostic company with a focus in lung disease, today announced plans to provide COVID-19 ddPCR diagnostic testing for Colorado State University (CSU) as students return to...
Learn MoreTerumo BCT Revamps Brand
By: Colorado BioScience Association Date: 08/11/2020
Terumo BCT is revamping its brand to Terumo Blood and Cell Technologies to reflect the company promise to unlock the potential of blood and cells and its heritage to innovate with customers to serve m...
Learn MoreSana Health raises $5.8M to get through clinical trials
By: Colorado BioScience Association Date: 08/06/2020
Sana Health Inc., is currently in the middle of its trials for the behavioral health device that uses a relaxation mask to relieve chronic pain and stress. Sana has raised $5.8 million in new venture...
Learn MoreTriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales
By: Colorado BioScience Association Date: 08/03/2020
SD-101 is a proprietary investigational, second-generation, Toll-like receptor 9 (TLR9) agonist CpG-C class oligodeoxynucleotide. TriSalus plans to further develop SD-101 as an oncology therapeutic. F...
Learn MoreColorado-based New Iridium accelerating global production of potential COVID-19 treatment using light-driven chemistry
By: Colorado BioScience Association Date: 07/17/2020
New Iridium, a company developing commercialized photocatalysis technologies to accelerate drug development and manufacturing, has been awarded a National Science Foundation (NSF) Small Business Tech...
Learn MoreKromaTiD Announces Launch of New Product, dGH In-Site™
By: Colorado BioScience Association Date: 06/30/2020
KromaTiD, Inc. announced today the launch of its new product dGH In-Site™, a single-cell, high resolution, genome-wide DNA insert tracking assay. dGH In-Site™ enables researchers to directly measure t...
Learn MoreBoulder Biotech Company to be Acquired for $1.4B
By: Colorado BioScience Association Date: 06/22/2020
Just a few weeks ago, the company filed for an IPO. Now, it's being acquired. Find out more in the article from Denver Business Journal.
Learn MoreBrickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering
By: Colorado BioScience Association Date: 06/18/2020
Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitati...
Learn MoreEdgewise Therapeutics Appoints Kirsten L. Gruis, M.D., M.S. as Chief Medical Officer
By: Colorado BioScience Association Date: 06/18/2020
Edgewise Therapeutics, a biopharmaceutical company developing small molecule therapies for musculoskeletal diseases, today announced the appointment of Kirsten L. Gruis, M.D., M.S. to the newly create...
Learn MoreArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM™) to Clinical Research
By: Colorado BioScience Association Date: 06/18/2020
ArcherDX, Inc. today announced it is entering into a collaboration with Bristol Myers Squibb (BMS) to utilize Personalized Cancer Monitoring (PCM™) assays to understand the potential benefits of minim...
Learn More